Amy B. Manning-Boğ, Ph.D., has joined MRIGlobal as its first chief innovation officer.   Manning-Boğ was formerly vice president, Drug Discovery & Translational Development for Atreca Inc. in South San Francisco, Calif. In this newly created role, she will be responsible for leading the identification and translation of MRIGlobal proprietary intellectual property into commercialization opportunities through licensing, royalties, and new business venture start-ups. She will also lead MRIGlo...